Contributions of Interfacial Residues of Human Interleukin15 to the Specificity and Affinity for Its Private α-Receptor

Journal of Molecular Biology

Volumn 389, Issue 5, 2009, Pages 880-894

  Sakamoto, Sou ^a   Caaveiro, Jose M M ^a   Sano, Emiko ^a   Tanaka, Yoshikazu ^a   Kudou, Motonori ^a   Tsumoto, Kouhei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

energetic hot spot; IL15; molecular recognition; protein protein interaction; surface plasmon resonance

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENERGY TRANSFER; ENTHALPY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; SURFACE PLASMON RESONANCE; THERMODYNAMICS;

EID: 67349282017     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.04.050     Document Type: Article

References (54)

1. + memory T cells by opposing cytokines. Science 288 (2000) 675-678
2. Fehniger T.A., and Caligiuri M.A. Interleukin 15: biology and relevance to human disease. Blood 97 (2001) 14-32
3. Bernasconi N.L., Traggiai E., and Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 (2002) 2199-2202
4. Waldmann T.A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6 (2006) 595-601
5. Bulfone-Paus S., Bulanova E., Budagian V., and Paus R. The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling. Bioessays 28 (2006) 362-377
6. c receptors. Science 310 (2005) 1159-1163
7. Giri J.G., Kumaki S., Ahdieh M., Friend D.J., Loomis A., Shanebeck K., et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 14 (1995) 3654-3663
8. Wang X., Lupardus P., La Porte S.L., and Garcia K.C. Structural biology of shared cytokine receptors. Annu. Rev. Immunol. 27 (2009) 1-32
9. van de Vosse E., and van Agtmael M.A. Targets of anticytokine therapy and the risk of infections in humans and mice. Curr. Opin. Rheumatol. 19 (2007) 626-635
10. Asquith D.L., and McInnes I.B. Emerging cytokine targets in rheumatoid arthritis. Curr. Opin. Rheumatol. 19 (2007) 246-251
11. Bodnár A., Nizsalóczki E., Mocsár G., Szalóki N., Waldmann T.A., Damjanovich S., and Vámosi G. A biophysical approach to IL-2 and IL-15 receptor function: localization, conformation and interactions. Immunol. Lett. 116 (2008) 117-125
12. Wei X.-Q., Orchardson M., Gracie J.A., Leung B.P., Bao-mei G., Guan H., et al. The Sushi domain of soluble IL-15 receptor α is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo. J. Immunol. 167 (2001) 277-282
13. Anderson D.M., Kumaki S., Ahdieh M., Bertles J., Tometsko M., Loomis A., et al. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 270 (1995) 29862-29869
14. Matsumoto M., Misawa S., Tsumoto K., Kumagai I., Hayashi H., and Kobayashi Y. On-column refolding and characterization of soluble human interleukin-15 receptor α-chain produced in Escherichia coli. Protein Expr. Purif. 31 (2003) 64-71
15. Mortier E., Quéméner A., Vusio P., Lorenzen I., Boublik Y., Grötzinger J., et al. Soluble interleukin-15 receptor α (IL-15R α)-sushi as a selective and potent agonist of IL-15 action through IL-15R β/γ. J. Biol. Chem. 281 (2006) 1612-1619
16. Rickert M., Wang X., Boulanger M., Goriatcheva N., and Garcia K.C. The structure of interleukin-2 complexed with its alpha receptor. Science 308 (2005) 1477-1480
17. Bernard J., Harb C., Mortier E., Quéméner A., Meloen R.H., Vermot-Desroches C., et al. Identification of an interleukin-15α receptor-binding site on human interleukin-15. J. Biol. Chem. 279 (2004) 24313-24322
18. Quéméner A., Bernard J., Mortier E., Plet A., Jacques Y., and Tran V. Docking of human interleukin-15 to its specific receptor α chain: correlation between molecular modeling and mutagenesis experimental data. Proteins 65 (2006) 623-636
19. Chen Y.W., Fersht A.R., and Henrick K. Contribution of buried hydrogen bonds to protein stability. The crystal structures of two barnase mutants. J. Mol. Biol. 234 (1993) 1158-1170
20. Urakubo Y., Ikura T., and Ito N. Crystal structural analysis of protein-protein interactions drastically destabilized by a single mutation. Protein Sci. 17 (2008) 1055-1065
21. Chirifu M., Hayashi C., Nakamura T., Toma S., Shuto T., Kai H., et al. Crystal structure of the IL-15-IL-15Rα complex, a cytokine-receptor unit presented in trans. Nat. Immunol. 8 (2007) 1001-1007
22. Liparoto S.F., Myszka D.G., Wu Z., Goldstein B., Laue T.M., and Ciardelli T.L. Analysis of the role of the interleukin-2 receptor γ chain in ligand binding. Biochemistry 41 (2002) 2543-2551
23. Shiroishi M., Tsumoto K., Tanaka Y., Yokota A., Nakanishi T., Kondo H., and Kumagai I. Structural consequences of mutations in interfacial Tyr residues of a protein antigen-antibody complex. J. Biol. Chem. 282 (2007) 6783-6791
24. Kumar S., and Nussinov R. Relationship between ion pair geometries and electrostatic strengths in proteins. Biophys. J. 83 (2002) 1595-1612
25. Sheinerman F.B., and Honig B. On the role of electrostatic interactions in the design of protein-protein interfaces. J. Mol. Biol. 318 (2002) 161-177
26. Schroers A., Hecht O., Kallen K.-J.J., Pachta M., Rose-John S., and Grötzinger J. Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane. Protein Sci. 14 (2005) 783-790
27. Clackson T., and Wells J.A. A hot spot of binding energy in a hormone-receptor interface. Science 267 (1995) 383-386
28. Bogan A.A., and Thorn K.S. Anatomy of hot spots in protein interfaces. J. Mol. Biol. 280 (1998) 1-9
29. DeLano W.L. Unraveling hot spots in binding interfaces: progress and challenges. Curr. Opin. Struct. Biol. 12 (2002) 14-20
30. Gohlke H., and Klebe G. Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors. Angew. Chem. Int. Ed. Engl. 41 (2002) 2644-2676
31. Chaires J.B. Calorimetry and thermodynamics in drug design. Annu. Rev. Biophys. 37 (2008) 135-151
32. Lo Conte L., Chothia C., and Janin J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285 (1999) 2177-2198
33. Wodak S.J., and Janin J. Structural basis of macromolecular recognition. Adv. Protein Chem. 61 (2002) 9-73
34. Tsumoto K., Ogasahara K., Ueda Y., Watanabe K., Yutani K., and Kumagai I. Role of salt bridge formation in antigen-antibody interaction. J. Biol. Chem. 271 (1996) 32612-32616
35. Katsumata K., Okazaki A., Tsurupa G.P., and Kuwajima K. Dominant forces in the recognition of a transient folding intermediate of alpha-lactalbumin by GroEL. J. Mol. Biol. 264 (1996) 643-649
36. Ross P.D., and Subramanian S. Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry 20 (1981) 3096-3102
37. Cleland W.W., and Northrop D.B. Energetics of substrate binding, catalysis, and product release. Methods Enzymol. 308 (1999) 3-27
38. Hantgan R.R., Stahle M.C., and Horita D.A. Entropy drives integrin αIIbβ3:echistatin binding-evidence from surface plasmon resonance spectroscopy. Biochemistry 47 (2008) 2884-2892
39. Olsen S.K., Ota N., Kishishita S., Kukimoto-Niino M., Murayama K., Uchiyama H., et al. Crystal Structure of the interleukin-15·interleukin-15 receptor α complex: insights into trans and cis presentation. J. Biol. Chem. 282 (2007) 37191-37204
40. Waldburger C.D., Schildbach J.F., and Sauer R.T. Are buried salt bridges important for protein stability and conformational specificity?. Nat. Struct. Biol. 2 (1995) 122-128
41. Krissinel E., and Henrick K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372 (2007) 774-797
42. Sheinerman F.B., Norel R., and Honig B. Electrostatic aspects of protein-protein interactions. Curr. Opin. Struct. Biol. 10 (2000) 153-159
43. Eriksson A.E., Baase W.A., Zhang X.J., Heinz D.W., Blaber M., Baldwin E.P., and Matthews B.W. Response of a protein structure to cavity-creating mutations and its relation to the hydrophobic effect. Science 255 (1995) 178-183
44. Buckle A.M., Cramer P., and Fersht A.R. Structural and energetic responses to cavity-creating mutations in hydrophobic cores: observation of a buried water molecule and the hydrophilic nature of such hydrophobic cavities. Biochemistry 35 (1996) 4298-4305
45. Ratnaparkhi G.S., and Varadarajan R. Thermodynamic and structural studies of cavity formation in proteins suggest that loss of packing interactions rather than the hydrophobic effect dominates the observed energetics. Biochemistry 39 (2000) 12365-12374
46. Bouchaud G., Garrigue-Antar L., Solé V., Quéméner A., Boublik Y., Mortier E., et al. The exon-3-encoded domain of IL-15Rα contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Rα. J. Mol. Biol. 382 (2008) 1-12
47. Lawrence M.C., and Colman P.M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234 (1993) 946-950
48. Yokota A., Tsumoto K., Shiroishi M., Kondo H., and Kumagai I. The role of hydrogen bonding via interfacial water molecules in antigen-antibody complexation. J. Biol. Chem. 278 (2003) 5410-5418
49. Burton J.D., Bamford R.N., Peters C., Grant A.J., Kurys G., Goldman C.K., et al. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl Acad. Sci. USA 91 (1994) 4935-4939
50. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., et al. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264 (1994) 965-968
51. c receptors. J. Mol. Biol. 339 (2004) 1115-1128
52. Thanos C.D., DeLano W.L., and Wells J.A. Hot-spot mimicry of a cytokine receptor by a small molecule. Proc. Natl Acad. Sci. USA 103 (2006) 15422-15427
53. Tsumoto K., Shinoki K., Kondo H., Uchikawa M., Juji T., and Kumagai I. Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent-application to a human single-chain Fv fragment. J. Immunol. Methods 219 (1998) 119-129
54. Asano R., Kudo T., Makabe K., Tsumoto K., and Kumagai I. Antitumor activity of interleukin-21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli. FEBS Lett. 528 (2002) 70-76